RALOXIFENE 60mg

For the best results in your research, proper handling of Dragon Pharma RALOXIFENE 60mg Pastilles is essential to maintain the structural integrity and potency of the SARM:

• Storage: Unlike lyophilized powder, pastilles should be stored in a cool, dry place (20°C to 25°C). Keep the container tightly sealed and protected from direct UV light and moisture. While refrigeration is not strictly required for solid forms, avoiding temperature fluctuations is critical to prevent the pastille matrix from softening.
• Handling: Research pastilles are designed for precise, pre-measured dosing. Handle with clean, dry laboratory tools or gloves to avoid cross-contamination or the introduction of moisture, which can degrade the active compound.
• Dissolution (If Required): While designed as a solid-form delivery system for oral administration in animal models, the RALOXIFENE 60mg within the pastille remains soluble in organic solvents such as DMSO or ethanol if liquid-phase analysis is necessary. Note that the binder materials in the pastille may not be fully soluble in these solvents.
• Shelf Life: In their original solid state, RALOXIFENE 60mg pastilles remain stable for up to 24 months when stored under optimal conditions. Avoid exposing the pastilles to high humidity, as the hygroscopic nature of certain binders can compromise the stability of the active Enobosarm molecule.